Navigation Links
Study shows gene's role in developing and maintaining cells key for a lifetime of memories

St. Jude Children's Research Hospital investigators showed a gene named Prox1 is a key player in normal development of a brain structure crucial for learning and memory and remains active throughout life, nurturing the cells vital for making new memories.

This study focused on a small region of the hippocampus known as the dentate gyrus, a brain structure needed for memory and learning that is home to the subgranular zone where the neural stem cells destined to become granule cells are housed. The dentate gyrus is one of two regions of the adult brain where neural stem cells continue to produce the precursor cells that ultimately differentiate into neurons.

Although investigators knew Prox1 was expressed during development of the dentate gyrus, this is the first report detailing the gene's function in this region of the brain. Prox1 is a transcription factor that functions like an on-off switch for genes.

Researchers showed that by removing Prox1 at different stages of mouse development, the dentate gyrus fails to develop properly. Investigators also demonstrated that Prox1 remains important throughout mammalian life to ensure production of new granule cells, which are needed to form new memories. The work appears in the August 17 edition of PloS Biology.

The findings raise the possibility that subtle mutations in Prox1 might be linked to memory and learning problems, said the paper's senior author Guillermo Oliver, Ph.D., member of the St. Jude Department of Genetics. "The more we understand about how signaling pathways work in the brain, the more we will eventually be able to manipulate the system to promote or block the differentiation process," he said.

Although this is the first detailed report of the role Prox1 plays in normal brain development, earlier studies suggest the gene is central to normal development in a wide range of organs and cell types. Prox1 also plays a role in several types of cancers.

In this study, investigators determined that in the adult mammalian brain, Prox1 is active during a particular stage of differentiation when neural stem cells change from cells of unlimited potential to more specialized granule cells. The scientists reported that in the dentate gyrus Prox1 is produced by intermediate progenitor cells and that the lack of Prox1 results in death of these intermediate cells. Without these intermediate progenitor cells, new adult granule cells do not develop.

Researchers also linked Prox1 to a feedback mechanism that signals stem cells to stop differentiating. "When we switched off the expression of the Prox1 gene in mice and the intermediate progenitor cells disappeared, the adult neural stem cells continued differentiating into granule cells until the supply of stem cells was exhausted. When we switched on Prox1 in these adult neural stem cells, we observed a similar depletion of stem cells caused by their premature differentiation," Oliver said. Investigators are still studying the signaling pathways involved.

The paper's first author, Alfonso Lavado, Ph.D., a postdoctoral fellow in Oliver's laboratory, added: "It was surprising to find out that the loss of Prox1 in intermediate progenitors impacted neural stem cells. Without the intermediate progenitors, their mother cells, the neural stem cells, also disappear. That shows the progeny is somehow needed to maintain the mother cells when new neuronal cells develop."

These findings indicate that during dentate gyrus development and adult neurogenesis, Prox1 is necessary for the differentiation of granule cells and reveals a regulatory mechanism that links the production of the proper number of new granule cells to the maintenance of adult stem cells.


Contact: Summer Freeman
St. Jude Children's Research Hospital

Related biology news :

1. Grant to study effects of oil and dispersants on Louisiana salt marsh ecosystem
2. Blood stem cell, leukemia link illuminated in UCSF-led study
3. Landmark dental school study uses genetic test to help predict gum disease
4. Illinois researchers use pyrosequencing to study canine intestinal bacteria
5. Study to examine rising sea levels impact on estuaries, coastal communities
6. Tinnitus study looks for cure to ringing in the ears
7. Texas petrochemical emissions down, but still underestimated, says study
8. $22.5 million grant funds international study of membrane proteins
9. Study shows that hitchhiking bacteria can go against the flow
10. Genome study identifies genetic variant linked to TB susceptibility in Africans
11. Genetic differences that make some people susceptible to meningitis revealed in major new study
Post Your Comments:
(Date:5/12/2016)... May 12, 2016 , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 27, 2016  Global demand for enzymes is ... 2020 to $7.2 billion.  This market includes enzymes ... products, biofuel production, animal feed, and other markets) ... biocatalysts). Food and beverages will remain the largest ... consumption of products containing enzymes in developing regions.  ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created ... and solutions to the healthcare market. The company's primary focus is on new ... and marketing strategies that are necessary to help companies efficiently bring their products ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology: